// App-Quantinova.ai

: Clazakizumab Acts on Endothelial Cells to Limit Antibody Mediated Damage

Researchers

Presenter

  • J. Lion

Principal Investigators

  • K. Poussin

  • E. Chong

  • D. Glotz

  • N. A. Mooney

Medical Centers

  • Alloimmunité-Autoimmunité-Transplantation, INSERM, Paris, France

  • Vitaeris, Inc, Vancouver, BC, Canada

  • Nephrology and Transplantation, Hôpital Saint Louis, Paris, France

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 4

Drug/Treatment

  • clazakizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved